pharma consulting

Reliable Experts in Pharmacology Market: Pharma Consultants

In the new fast-paced world, with unlimited access to information and technology, it gets overwhelming for various companies, be it an established goliath or a new start-up, to take important deci...

GSK’s RSV vaccine; SparingVision’s interest in gene therapy; InCarda’s raise; B...

GSK eyes robust immune response from RSV vaccineCold viruses mostly do not get much attention in terms of R&D. They usually make humans feel miserable for a few days, and later than clear...

Samsung/AZ Deal; Gyroscope’s Dry AMD Gene Therapy; Inflazome’s Buyout; Abbott’s MitraClip4 ...

Samsung Biologics strikes a USD 330.8 Mn supply deal with AstraZeneca Samsung Biologics announced the conclusion of a long-term supply deal with AstraZeneca worth USD 330.8 Million. ...

Omega’s sixth funding round; Correvio’s drug failure; and BIMA acquisition

A leading global international investment firm, Omega Funds has announced the closure of its sixth fundraising USD 438 Million.More than decade old Life Sciences-based investment firm special...

Acquisition of ArQule; Synthorx; and Zentalis nabs a raise

Merck is set to complete the already planned purchase of the ArQule for USD 2.7 Billion.Under the terms of the agreement, Merck will pay USD 20 for each share in cash for a total amount of US...

EicOsis receives USD 15M to fuel its non-opioid pain therapy; Alexion Pharmaceuticals buys Achill...

EicOsis has received USD 15Million grant from the National Institute of Drug Abuse (NIDA) to fund the clinical trials of non-opioid pain therapy.NIDA, with an aim to supplement NIH’s initiati...

EU approval for Imbruvica; Pharming licenses orphan drug

EU recommends the use of Imbruvica for two new indicationsThe Janssen Pharmaceutical has received the approval for its drug Imbruvica (ibrutinib) from the European Commission (EC). Ibrutinib i...

Notizia

Arming antibiotics with a vaccination-like immune responseHarnessing the ability of the body’s immune system has already well-tried to be effective in treating cancer. Marcos Pires, Ph.D., a Le...

Allergic Conjunctivitis (AC)- Market Insights, Epidemiology and Market Forecast- 2027

NF-κB Inhibitors- A Promising Future

NF-κB (Nuclear Factor kappa-light-chain-enhancer of activated B cells) is a protein transcription factor that can orchestrate complex biological processes such as cell survival, cytokine production...